Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550654 · ClinicalTrials.gov registry record · Phase 2
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
A Phase 2 study, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00550654 is a Phase 2 study that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1 participants.
The verdict
NCT00550654, a Phase 2 study, was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well conformal radiation therapy works in treating patients with metastatic cancer outside the brain.
Interventions
- OTHER questionnaire administration
- RADIATION hypofractionated radiation therapy
- RADIATION image-guided radiation therapy
- RADIATION 3-dimensional conformal radiation therapy
- RADIATION tomotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00550654
The ClinicalTrials.gov registry entry for NCT00550654 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00550654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00550654 about?
NCT00550654 is a clinical study titled "Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain". RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well conformal radiation therapy works in treating patients with metastatic cancer out...
What is the current status of trial NCT00550654?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2007-10. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00550654?
The interventions under investigation include: questionnaire administration (OTHER), hypofractionated radiation therapy (RADIATION), image-guided radiation therapy (RADIATION), 3-dimensional conformal radiation therapy (RADIATION), tomotherapy (RADIATION).
Who is sponsoring clinical trial NCT00550654?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.